DTaP-Hib vaccine
Combination vaccine
From Wikipedia, the free encyclopedia
DTaP-Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed with Haemophilus B conjugate vaccine, sometimes abbreviated to DTaP-Hib.[2] It protects against the infectious diseases diphtheria, tetanus, pertussis, and Haemophilus influenzae type B.[3][4]
Trade namesTriHIBit[1]
Routes of
administrationIntramuscular injection
administrationIntramuscular injection
| Combination of | |
|---|---|
| DTaP vaccine | Vaccine |
| Hib vaccine | Vaccine |
| Clinical data | |
| Trade names | TriHIBit[1] |
| Routes of administration | Intramuscular injection |
| ATC code | |
| Identifiers | |
| CAS Number | |
A branded formulation was marketed in the US as TriHIBit by Sanofi Pasteur, and administered by using the Sanofi DTaP vaccine Tripedia to reconstitute the Sanofi Hib vaccine ActHIB.[3][5][6] TriHIBit and Tripedia were discontinued in 2011.[7]
